Hemolytic-Uremic Syndrome clinical trials at UCSD

1 research study open to eligible people

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
open to eligible people ages 9 months to 21 years
The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).
La Jolla, California and other locations

Last updated: September 2022

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection